Insulet
PODD
#1641
Rank
A$18.31 B
Marketcap
A$264.40
Share price
-1.38%
Change (1 day)
-34.96%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): A$0.60 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.70 Billion. , an increase over its 2024 earnings that were of A$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 A$0.55 B16.27%
2024 A$0.47 B36.76%
2023 A$0.34 B481.9%
2022 A$60.11 M-45.24%
2021 A$0.10 B43.35%
2020 A$76.57 M18.51%
2019 A$64.61 M41.16%
2018 A$45.77 M-711.95%
2017 -A$7.49 Million-56.85%
2016 -A$17.34 Million-79.31%
2015 -A$83.81 Million63.85%
2014 -A$51.15 Million31.04%
2013 -A$39.04 Million-21.96%
2012 -A$50.02 Million
2010 -A$47.71 Million-42.38%
2009 -A$82.8 Million-33.56%
2008 -A$0.13 Billion65.93%
2007 -A$75.11 Million209.75%
2006 -A$24.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.79 B 8,313.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.80 B 2,022.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$8.75 B 1,473.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$35.88 B 6,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.29 Billion-151.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.13 B-75.50%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.54 B 177.51%๐Ÿ‡บ๐Ÿ‡ธ USA